Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-28T21:55:00.287Z Has data issue: false hasContentIssue false
  • English
  • Français

A Controlled Clinical Trial of Methylpentynol (“Oblivon”)

Published online by Cambridge University Press:  08 February 2018

S. Bockner
S. Bockner*
Affiliation:
North Middlesex Hospital, Edmonton, London, N.18
Get access Rights & Permissions [Opens in a new window]

Extract

There have been many new types of sedatives and hypnotics evolved in recent years. The term “tranquillizing drug” is a recent innovation which suggests a calming effect without a hypnotic effect. Methylpentynol (“Oblivon”) is one such drug which has little hypnotic action, but is said specifically to relieve anxiety. This action was noted by the relief of apprehension observed in patients prior to dental treatment (Trotter, 1953). Methylpentynol is a higher alcohol which in high dosage has a hypnotic effect in animals (Margolin et al., 1951). No toxic effects have been reported. It is made up in rather large, blue-green capsules containing 250 mg. of methylpentynol, and also as an elixir.

Type
Original Articles
Information
Journal of Mental Science , Volume 103 , Issue 430 , January 1957 , pp. 218 - 221
Copyright
Copyright © Royal College of Psychiatrists, 1957 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Boag, A. G., Brit. med. J., 1954, ii, 393.CrossRefGoogle Scholar
Margolin, S., Perlman, P., Villani, F., and McGavack, T. H., Science, 1951, 114, 384.Google Scholar
Trotter, P. A., Dental Practitioner, 1953, 8, 376.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.